Phreesia, Inc. (NYSE:PHR) Insider Sells $16,473.35 in Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) insider Yvonne Hui sold 571 shares of the firm's stock in a transaction on Monday, July 7th. The shares were sold at an average price of $28.85, for a total transaction of $16,473.35. Following the completion of the transaction, the insider directly owned 31,010 shares of the company's stock, valued at approximately $894,638.50. This trade represents a 1.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Yvonne Hui also recently made the following trade(s):

• On Tuesday, June 10th, Yvonne Hui sold 582 shares of Phreesia stock. The shares were sold at an average price of $28.00, for a total value of $16,296.00.
• On Monday, April 21st, Yvonne Hui sold 993 shares of Phreesia stock. The stock was sold at an average price of $23.04, for a total value of $22,878.72.
• On Tuesday, April 15th, Yvonne Hui sold 314 shares of Phreesia stock. The shares were sold at an average price of $24.04, for a total value of $7,548.56.

Phreesia Stock Performance

NYSE:PHR traded down $1.93 during mid-day trading on Friday, hitting $26.74. 504,545 shares of the stock were exchanged, compared to its average volume of 456,712. The firm's 50-day simple moving average is $26.34 and its 200 day simple moving average is $26.36. The stock has a market capitalization of $1.59 billion, a price-to-earnings ratio of -36.13 and a beta of 0.72. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $30.53. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.95 and a current ratio of 1.95.

Phreesia (NYSE:PHR - Get Free Report) last posted its earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. Phreesia had a negative return on equity of 16.23% and a negative net margin of 9.83%. The company had revenue of $115.94 million during the quarter, compared to the consensus estimate of $115.00 million. During the same quarter last year, the firm earned ($0.05) earnings per share. The company's revenue was up 14.5% on a year-over-year basis. As a group, equities analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have issued reports on PHR shares. Needham & Company LLC reaffirmed a "buy" rating and set a $29.00 price target on shares of Phreesia in a research report on Thursday, March 13th. Truist Financial upped their target price on shares of Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a report on Thursday, May 29th. Wall Street Zen upgraded Phreesia from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. Citigroup reissued a "buy" rating on shares of Phreesia in a research report on Wednesday, May 28th. Finally, DA Davidson cut their price objective on Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a research report on Monday, April 14th. Twelve analysts have rated the stock with a buy rating, According to MarketBeat, Phreesia has an average rating of "Buy" and a consensus target price of $31.64.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in PHR. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Phreesia by 108.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,644,988 shares of the company's stock worth $67,606,000 after buying an additional 1,377,904 shares during the last quarter. American Century Companies Inc. lifted its holdings in Phreesia by 3,741.9% during the 1st quarter. American Century Companies Inc. now owns 983,440 shares of the company's stock worth $25,137,000 after buying an additional 957,842 shares during the period. Deerfield Management Company L.P. Series C boosted its holdings in Phreesia by 133.6% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 1,271,832 shares of the company's stock valued at $31,999,000 after acquiring an additional 727,384 shares during the last quarter. Greenhouse Funds LLLP increased its position in shares of Phreesia by 27.9% during the fourth quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company's stock worth $72,307,000 after buying an additional 626,579 shares during the period. Finally, Nuveen LLC bought a new position in shares of Phreesia in the 1st quarter worth about $14,206,000. Institutional investors and hedge funds own 92.10% of the company's stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.